MeVis Medical Solutions AG (ETR:M3V)
23.60
0.00 (0.00%)
Aug 5, 2026, 5:35 PM CET
ETR:M3V Balance Sheet
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Cash & Short-Term Investments | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Cash Growth | -44.06% | -0.06% | -15.70% | -16.91% | 22.30% | 92.76% |
Accounts Receivable | 1.98 | 1.51 | 2.24 | 2.65 | 4.01 | 2.27 |
Other Receivables | 0.49 | 0.67 | 0.52 | 0.62 | 0.73 | 0.53 |
Total Trade Receivables | 2.48 | 2.18 | 2.77 | 3.27 | 4.74 | 2.8 |
Other Current Assets | 0.52 | 1.88 | 1.87 | 1.84 | 1.94 | 2.19 |
Total Current Assets | 6.39 | 8.96 | 9.55 | 11.33 | 14.37 | 10.77 |
Net Property, Plant & Equipment | 0.29 | 0.31 | 0.32 | 0.15 | 0.16 | 0.12 |
Other Intangible Assets | - | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 16.23 | 16.53 | 16.53 | 16.54 | 16.54 | 16.54 |
Total Assets | 23.16 | 25.89 | 26.48 | 28.05 | 31.2 | 27.53 |
Accounts Payable | 0.74 | 3.31 | 4.65 | 5 | 7.98 | 4.79 |
Accrued Expenses | 1.95 | 2.11 | 2.05 | 2.95 | 3 | 2.28 |
Unearned Revenue | 0.52 | 0.71 | 0.01 | 0.01 | 0.02 | 0.03 |
Other Current Liabilities | 0.21 | 0.16 | 0.18 | 0.36 | 0.34 | 0.4 |
Total Current Liabilities | 3.42 | 6.29 | 6.89 | 8.32 | 11.34 | 7.49 |
Other Long-Term Liabilities | 1.91 | 0.23 | 0.25 | 0.27 | 0.54 | 0.48 |
Total Long-Term Liabilities | 1.91 | 0.23 | 0.25 | 0.27 | 0.54 | 0.48 |
Total Liabilities | 5.34 | 6.52 | 7.13 | 8.58 | 11.88 | 7.98 |
Common Stock | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 |
Additional Paid-in Capital | 11.46 | 11.46 | 11.46 | 11.46 | 11.46 | 11.46 |
Retained Earnings | 4.54 | 4.54 | 4.54 | 4.54 | 4.54 | 4.54 |
Shareholders' Equity | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 |
Total Liabilities & Equity | 23.16 | 25.89 | 26.48 | 28.05 | 31.2 | 27.53 |
Net Cash (Debt) | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Net Cash Growth | -44.06% | -0.06% | -15.70% | -16.91% | 22.30% | 92.76% |
Net Cash Per Share | 2.00 | 3.58 | 3.59 | 4.25 | 5.12 | 4.19 |
Book Value | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 |
Book Value Per Share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
Tangible Book Value | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 |
Tangible Book Value Per Share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |